• Published in Patient Preference and Adherence

  • Collaborator: AstraZeneca

  • Authors: Simacek K, Curran C, Fenici P, Garcia-Sanchez R

This study aimed to assess awareness of glycated hemoglobin (A1C) testing and targets, perceived level of glycemic control and risk of complications, attitudes toward medications and self-management, and regimen-related distress in an international sample of patients with type 2 diabetes (T2D).